RAC supplies reference standards for 1 2R,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic Acid impurities, including (2R,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic Acid. Every lot is released with a certificate stating HPLC purity, MS and 1H NMR data, produced under ISO 17034:2016 (ANAB, AR-2832). All items are scheduled on synthesis, typically 3-4 weeks. Pharmacopoeial items follow the monograph numbering (EP, USP, BP); non-pharmacopoeial items are characterised against the drawn structure, and can be re-qualified against your own method on request.
| Standard | CAS | Status | |
|---|---|---|---|
| (2R,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic Acid | 2064219-13-0 | On synthesis |
Prices are quoted per enquiry — pack size, documentation and shipping are confirmed together.
Metabolites, NDSRI nitrosamines and degradation products of 2R,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic Acid that no catalogue lists — typically 3–4 weeks from 10 mg to gram scale, released with the same certificate.
—